Prenatal molecular diagnosis and allogeneic hematopoietic stem cell transplantation in an infant with RAG2 deficiency
DOI:
https://doi.org/10.46765/2675-374X.2025v7n1e370Keywords:
Hematopoietic stem cell transplantation, Pediatrics, Severe combined immunodeficiencyAbstract
RAG2 deficiency is a cause of severe combined immunodeficiency (SCID), characterized by a defect in the development of T and B lymphocytes that predisposes patients to life-threatening infections during the first months of life. We present the case of an infant with a prenatal molecular diagnosis of SCID secondary to RAG2 deficiency who underwent allogeneic hematopoietic stem cell transplantation (HSCT) using a human leukocyte antigen-identical sibling donor at 3 months old. The subsequent clinical course was favorable, with successful immune reconstitution. This case highlights the impact of prenatal molecular diagnosis on the implementation of preventive measures, the performance of early HSCT, and the optimization of clinical outcomes in patients with RAG2 deficiency.
References
1. Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino-Neto A, Bezrodnik L, Ali A, Adeli M, Drabwell J. Primary immunodeficiencies: a decade of progress and a promising future. Front Immunol. 2020;11:625753. https://doi.org/10.3389/fimmu.2020.625753
2. Quinn J, Modell V, Orange JS, Modell F. Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network. Allergy Asthma Clin Immunol. 2022;18(1):19. https://doi.org/10.1186/s13223-022-00662-6
3. Notarangelo LD, Kim MS, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. 2016;16(4):234-46. https://doi.org/10.1038/nri.2016.28
4. Karaatmaca B, Cagdas D, Esenboga S, Erman B, Tan C, Turul Ozgur T, Boztug K, van der Burg M, Sanal O, Tezcan I. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre. Clin Exp Immunol. 2024;215(2):160-76. https://doi.org/10.1093/cei/uxad110
5. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood. 2002;99(3):872-8. https://doi.org/10.1182/blood.v99.3.872
6. Heimall J, Puck J, Buckley R, Fleisher TA, Gennery AR, Neven B, Slatter M, Haddad E, Notarangelo LD, Baker KS, Dietz AC, Duncan C, Pulsipher MA, Cowan MJ. Current knowledge and priorities for future research in late effects after hematopoietic stem cell transplantation (HCT) for severe combined immunodeficiency patients: a consensus statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant. 2017;23(3): 379-87. https://doi.org/10.1016/j.bbmt.2016.12.619
7. Lankester AC, Albert MH, Booth C, Gennery AR, Güngör T, Hönig M, Morris EC, Moshous D, Neven B, Schulz A, Slatter M, Veys P; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immune Deficiencies, and European Reference Network on Rare Primary Immunodeficiency Autoinflammatory Autoimmune diseases (RITA). EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052-62. https://doi.org/10.1038/s41409-021-01378-8
8. Chen K, Wu W, Mathew D, Zhang Y, Browne SK, Rosen LB, McManus MP, Pulsipher MA, Yandell M, Bohnsack JF, Jorde LB, Notarangelo LD, Walter JE. Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations. J Allergy Clin Immunol. 2014;133(3):880-2.e10. https://doi.org/10.1016/j.jaci.2013.11.038
9. Schuetz C, Gerke J, Ege M, Walter J, Kusters M, Worth A, Kanakry JA, Dimitrova D, Wolska-Kuśnierz B, Chen K, Unal E, Karakukcu M, Pashchenko O, Leiding J, Kawai T, Amrolia PJ, Berghuis D, Buechner J, Buchbinder D, Cowan MJ, Gennery AR, Güngör T, Heimall J, Miano M, Meyts I, Morris EC, Rivière J, Sharapova SO, Shaw PJ, Slatter M, Honig M, Veys P, Fischer A, Cavazzana M, Moshous D, Schulz A, Albert MH, Puck JM, Lankester AC, Notarangelo LD, Neven B. Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT. Blood. 2023;141(7):713-24. https://doi.org/10.1182/blood.2022017667
10. Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, Mahlaoui N, Debré M, Casanova JL, Dal Cortivo L, Madec Y, Hacein-Bey-Abina S, de Saint Basile G, de Villartay JP, Blanche S, Cavazzana-Calvo M, Fischer A. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113(17):4114-24. https://doi.org/10.1182/blood-2008-09-177923
11. Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, Schwarz K, Schulz AS, Hoenig M, Sparber-Sauer M, Gatz SA, Denzer C, Blanche S, Moshous D, Picard C, Horn BN, de Villartay JP, Cavazzana M, Debatin KM, Friedrich W, Fischer A, Cowan MJ. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123(2):281-9. https://doi.org/10.1182/blood-2013-01-476432
12. Villa A, Capo V, Castiello MC. Innovative cell-based therapies and conditioning to cure RAG deficiency. Front Immunol. 2020;11:607926. https://doi.org/10.3389/fimmu.2020.607926
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maria Laura Herrera Andino, Milagros López Orozco, María Victoria Suen, Carlos Hernán Hollmann, Lucía Spossito, Arjan Lankester, María Emilia Mas, Ana Lisa Basquiera
This work is licensed under a Creative Commons Attribution 4.0 International License.
